참고문헌
- Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-1997. https://doi.org/10.1046/j.1523-1755.1999.00444.x
- Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006;1:79-87.
- Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005;67:2361-2367. https://doi.org/10.1111/j.1523-1755.2005.00342.x
- Cointault O, Kamar N, Bories P, et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004;19:171-178. https://doi.org/10.1093/ndt/gfg488
- Munjal S, Ejaz AA. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations. Nephrology (Carlton) 2006;11:405-409. https://doi.org/10.1111/j.1440-1797.2006.00653.x
- Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004;30:260-265. https://doi.org/10.1007/s00134-003-2047-x
- Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30. https://doi.org/10.1016/S0140-6736(00)02430-2
- Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000;26:1652-1657. https://doi.org/10.1007/s001340000691
- Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575-578. https://doi.org/10.1007/s00134-003-1672-8
- Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005;20:155-161. https://doi.org/10.1016/j.jcrc.2005.01.001
- Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33:1563-1570. https://doi.org/10.1007/s00134-007-0754-4
- Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-374. https://doi.org/10.1046/j.1523-1755.2001.00809.x
- Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-981. https://doi.org/10.1038/ki.1990.300
- Brophy PD, Somers MJ, Baum MA, et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 2005;20:1416-1421. https://doi.org/10.1093/ndt/gfh817
피인용 문헌
- Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy vol.38, pp.1, 2012, https://doi.org/10.1007/s00134-011-2438-3
- References vol.2, pp.1, 2012, https://doi.org/10.1038/kisup.2011.38
- Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution vol.16, pp.3, 2012, https://doi.org/10.1186/cc11403
- Regional Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy: A Meta-Analysis of Randomized Controlled Trials vol.59, pp.6, 2011, https://doi.org/10.1053/j.ajkd.2011.11.030
- Continuous renal replacement therapy in neonates weighing less than 3 kg vol.55, pp.8, 2011, https://doi.org/10.3345/kjp.2012.55.8.286
- Regional citrate anticoagulation for renal replacement therapy vol.20, pp.4, 2011, https://doi.org/10.3918/jsicm.20.577
- Regional Citrate Anticoagulation for RRTs in Critically Ill Patients with AKI vol.9, pp.12, 2011, https://doi.org/10.2215/cjn.01280214
- Zitratantikoagulation in der akuten Nierenersatztherapie : Methode der Wahl vol.109, pp.5, 2014, https://doi.org/10.1007/s00063-013-0339-7
- Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group “Renal Replacement Therapies in Critically Ill Patie vol.28, pp.2, 2011, https://doi.org/10.1007/s40620-014-0160-2
- Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement vol.61, pp.4, 2015, https://doi.org/10.1097/mat.0000000000000226
- Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk : A Randomized Clinical Trial vol.94, pp.52, 2011, https://doi.org/10.1097/md.0000000000002392
- Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials vol.20, pp.None, 2011, https://doi.org/10.1186/s13054-016-1299-0
- Evaluating the safety and efficacy of regional citrate compared to systemic heparin as anticoagulation for continuous renal replacement therapy in critically ill patients: A service evaluation followi vol.18, pp.3, 2017, https://doi.org/10.1177/1751143717695835
- The Role of Ionized Calcium and Magnesium in Regional Citrate Anticoagulation and its Impact on Inflammatory Parameters vol.40, pp.1, 2011, https://doi.org/10.5301/ijao.5000558
- Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure vol.12, pp.8, 2011, https://doi.org/10.1371/journal.pone.0182134
- Regional citrate anticoagulation for continuous renal replacement therapy vol.24, pp.6, 2018, https://doi.org/10.1097/mcc.0000000000000547
- A cost comparison of regional citrate versus low-dose systemic heparin anticoagulation in continuous renal replacement therapy vol.47, pp.3, 2011, https://doi.org/10.1177/0310057x18824596
- Regional Citrate Anticoagulation Protocol for Patients with Presumed Absent Citrate Metabolism vol.2, pp.2, 2011, https://doi.org/10.34067/kid.0005342020